Journal of Natural Products
Article
late eluate (30 mg) with H2O/MeOH (80:20, v/v) was also
rechromatographed over an MCI-gel CHP-20P column (1.1 i.d. ×
21 cm) with H2O and H2O/MeOH (90:10 → 85:15 → 80:20 →
75:25 and 0:100, v/v), and preparative HPLC purification of the H2O/
MeOH (75:25, v/v) eluate (55 mg) with solvent II yielded nilotinin
M7 (3) (9.0 mg). The T2 fractions 211−264 (555 mg), eluted with
EtOH/H2O (70:30, v/v), were subjected to an MCI-gel CHP-20P
column (1.1 i.d. × 37 cm) with H2O and H2O/MeOH (90:10 →
85:15 → 80:20 → 75:25 →70:30 and 0:100, v/v). The late eluate with
H2O/MeOH (80:20, v/v) (43 mg) with preparative HPLC
purification with solvent II yielded nilotinin M6 (2) (7.2 mg). The
T2 fractions 265−318 (535 mg), early eluted with EtOH/H2O (70:30,
v/v)/acetone/H2O (70:30, v/v) (90:10, v/v), were subjected to an
MCI-gel CHP-20P column (1.1 i.d. × 37 cm) with H2O and H2O/
MeOH (90:10 → 85:15 → 80:20 → 75:25 →70:30 and 0:100, v/v),
and the late eluate with H2O/MeOH (75:25, v/v) (59 mg) was
rechromatographed over the same column with H2O/MeOH (80:20
→ 75:25 → 70:30 and 0:100, v/v). The eluate (42.0 mg) with H2O/
MeOH (75:25 and 70:30, v/v) was subjected to preparative HPLC
purification with solvent III to yield nilotinin D9 (10) (5.4 mg) and
hirtellin F (6.3 mg), respectively.
A part (3.6 g) of the T1 fraction 5 (4.6 g), eluted with EtOH−H2O
(70:30, v/v)/acetone/H2O (70:30, v/v) (70:30, v/v), was rechroma-
tographed on a Toyopearl HW-40 (coarse) column (2.2 i.d. × 45 cm)
with EtOH/H2O (70:30, v/v)/acetone/H2O (70:30, v/v) (90:10 →
80:20 → 70:30, v/v), successively. The eluate (1.4g) with EtOH/H2O
(70:30, v/v)/acetone/H2O (70:30, v/v) (80:20) was subjected to an
MCI-gel CHP-20P column (1.1 i.d. × 36 cm) with H2O and H2O/
MeOH (95:5 → 90:10 → 85:15 → 80:20 → 75:25 → 70:30 → 60:40
and 0:100, v/v), yielding 600 MCI fractions (MCIfrs, 600 drops each).
The MCIfrs 11−60 (159 mg) and the MCIfrs 61−195 (235 mg),
eluted with H2O/MeOH (85:15, v/v), were separately rechromato-
graphed over a Sephadex LH-20 column (2.2 i.d. × 21 cm) with
EtOH/H2O (70:30, v/v), EtOH/H2O (70:30, v/v)/acetone/H2O
(70:30, v/v) (90:10, v/v), and acetone/H2O (70:30, v/v), and the
crude tannins (69 mg) in the eluate with EtOH/H2O (70:30, v/v)/
acetone/H2O (70:30, v/v) (90:10, v/v) from these Sephadex columns
yielded hirtellin T2 (6) (15.2 mg) upon preparative HPLC purification
with solvents I and II, respectively. The MCIfrs 196−300 (268 mg),
eluted with H2O/MeOH (80:20, v/v), were subjected to an MCI-gel
CHP-20P column (1.1 i.d. × 37 cm) with H2O and H2O/MeOH
(95:5 → 90:10 → 85:15 → 80:20 → 75:25 → 70:30 → 60:40 and
0:100, v/v), and the early eluate (57 mg) with H2O/MeOH (70:30, v/
v) was purified by preparative HPLC with solvent IV to afford hirtellin
T2 (6) (7.55 mg) and nilotinin T1 (5) (16.6 mg). The MCIfrs 301−
471 (496 mg), eluted with H2O/MeOH (75:25, v/v), were subjected
to a Sephadex LH-20 column (1.1 i.d. × 37 cm) with EtOH/H2O
(70:30, v/v), EtOH−H2O (70:30, v/v)/acetone/H2O (70:30, v/v)
(90:10 → 80:20, v/v), and acetone/H2O (70:30, v/v), and the crude
tannins (32 mg) in the EtOH/H2O (70:30, v/v) eluate yielded
hirtellin C (11) (7 mg) upon preparative HPLC purification with
solvent II. The early eluate with EtOH/H2O (70:30, v/v)/acetone/
H2O (70:30, v/v) (90:10, v/v) (88.7 mg) from the Sephadex column
was dissolved in MeOH. Tamarixinin B (8) (29 mg) was obtained as
an MeOH-insoluble fraction, whereas the MeOH-soluble fraction was
purified by preparative HPLC with solvent IV and yielded additional
crops of tamarixinin B (8) (10 mg) and nilotinin T1 (5) (9.3 mg). The
MCIfrs 523−572 (72 mg), eluted with H2O/MeOH (60:40, v/v),
were rechromatographed over an MCI-gel CHP-20P column (1.1 i.d.
× 21 cm) with H2O and H2O/MeOH (70:30 → 60:40 and 0:100, v/
v). Preparative HPLC purification of the eluate with H2O/MeOH
(60:40, v/v) (17 mg) with solvent V afforded tamarixinin C (9) (5.7
mg).
6.46 (1H, d, J = 1.8 Hz, DHDG H-2), and glucose protons (Table 1);
13C NMR assignments, see Tables 2 and 3; FABMS m/z 1297 [M +
Na]+; HRESIMS m/z 1297.10358 [M + Na]+ (calcd for C55H38O36
Na, 1297.10350).
Nilotinin M6 (2): off-white, amorphous powder; [α]18D +20.5 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 218.5 (5.43), 264 (5.04); CD
(MeOH) [θ] (nm) +1.5 × 105 (236), −7.6 × 104 (262), +4.8 × 104
1
(286); H NMR (acetone-d6/D2O, 9:1) δH 7.06, 6.99 [each 2H, s,
isoDHDG (H-2/H-6) × 2], 6.97 [2H, s, galloyl (H-2/H-6)], 6.87,
6.84 [each 1H, s, isoDHDG (H-6′) × 2], 6.60 (1H, s, HHDP H-3),
6.49 (1H, s, HHDP H-3′), and glucose protons (Table 1); 13C NMR
assignments, see Tables 2 and 3; HRESIMS m/z 1297.10145 [M +
Na]+ (calcd for C55H38O36Na, 1297.10351).
Nilotinin M7 (3): off-white, amorphous powder; [α]25D +21.4 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 217.5 (5.11), 274 (4.74); CD
(MeOH) [θ] (nm) +1.1 × 105 (237), −3.3 × 104 (262), +2.3 × 104
1
(283); H NMR (acetone-d6/D2O, 9:1) δH 7.07 [2H, s, galloyl-A (H-
2/H-6)], 6.968, [2H, s, isoDHDG (H-2/H-6)], 6.965 [2H, s, galloyl-B
(H-2/H-6)], 6.81 (1H, s, isoDHDG H-6′), 6.60 (1H, s, HHDP H-3),
6.48 (1H, s, HHDP H-3′), and glucose protons (Table 1); 13C NMR
assignments, see Tables 2 and 3; FABMS m/z 1229 [M + Na]+;
HRESIMS m/z 1129.09566 [M + Na]+ (calcd for C48H34O31Na,
1129.09763).
Nilotinin D10 (4): off-white, amorphous powder; [α]27 +53.1 (c
D
1.0, MeOH); UV (MeOH) λmax (log ε) 218.5 (5.43), 277 (5.08); CD
(MeOH) [θ] (nm) +0.9 × 105 (238), −1.6 × 104 (266), +2.6 × 104
(291); 1H NMR (acetone-d6/D2O, 9:1) δH 7.13, 6.95 [each 1H, d, J =
1.8 Hz, (DHDG H-6) × 2], 7.06, 7.02 [each 1H, s, (DHDG H-6′) ×
2], 7.03, 6.948, 6.92 [each 2H, s, galloyl (H-2/H-6) × 3], 6.58 (1H, s,
HHDP H-3), 6.51 (1H, s, HHDP H-3′), 6.37, 6.31 [each 1H, d, J =
1.8 Hz, (DHDG H-2) × 2], and glucose protons (Table 1); 13C NMR
assignments, see Tables 2 and 3; FABMS m/z 1763 [M + Na]+;
HRESIMS m/z 1763.17637 [M + Na]+ (calcd for C75H56O49 Na,
1763.17824).
Nilotinin T1 (5): off-white, amorphous powder; [α]31 −5.8 (c 1.0,
D
MeOH); UV (MeOH) λmax (log ε) 218 (5.63), 274.5 (5.28); CD
(MeOH) [θ] (nm) +4.2 × 105 (235), −1.9 × 105 (262), +1.2 × 105
1
(286); H NMR (acetone-d6/D2O, 9:1) δH 7.15, 6.99 [each 1H, s,
(DHDG H-6′) × 2], 7.04, 6.81 [each 1H, br s, (DHDG H-6) × 2],
6.48 and 6.44 [each 1H, br s, (DHDG H-2) × 2], 6.97 (2H, br s,
isoDHDG H-2/H-6), 6.76 (1H, br s, isoDHDG H-6′), 7.09, 6.972,
and 6.968 [each 2H, s, galloyl (H-2/H-6) × 3], 6.62, 6.60, and 6.58
[each 1H, s, HHDP (H-3′) × 3], 6.53, 6.52, 6.51 [each 1H, s, HHDP
(H-3) × 3], and glucose protons (Table 1); 13C NMR assignments,
see Tables 2 and 3; HRESIMS m/z 2831.24916 [M + Na]+ (calcd for
C123H84O78Na, 2831.24989).
Chemical Conversion of Nilotinin M7 (3) into Remurin A. A
solution of 3 (2 mg) in 200 μL of phosphate buffer (pH 7.4)
containing 1 drop of acetone was warmed at 37 °C for 1 h. The
reaction mixture was acidified with 1 N HCl and poured into a Sep-
Pak C18 cartridge. Inorganic solutes were washed out from the
cartridge with H2O, while adsorbed tannin was recovered (1.9 mg)
with MeOH. Conversion of 3 into remurin A was monitored by co-
chromatographic analyses with standard samples isolated from the
plant on normal-phase (tR 6.48 min, remurin A and 3) and reversed-
phase HPLC (tR 7.02 min for remurin A and tR 9.70 min for 3) and
1
was confirmed by the H NMR data comparison.
Chemical Conversion of Nilotinin T1 (5) into Hirtellin T2 (6). A
solution of 5 (2 mg) in 200 μL of phosphate buffer (pH 7.4)
containing 1 drop of acetone was incubated at 37 °C for 2 h. The
experiment was completed as mentioned above. A conversion of 5 into
6 was detected by co-chromatographic analyses with standard samples
isolated from the plant on normal-phase (tR 15.56 min, 5 and 6) and
reversed-phase HPLC (tR 5.76 min for 1 and tR 5.28 min for 6) and
Nilotinin M5 (1): off-white, amorphous powder; [α]26D +23.6 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 218.5 (5.05), 270 (4.7); CD
(MeOH) [θ] (nm) [θ] +0.75 × 105 (236), −1.8 × 104 (265), +1.3 ×
104 (285); 1H NMR (acetone-d6/D2O, 9:1, 600 MHz) δH 7.21 (1H, d,
J = 1.8 Hz, DHDG H-6), 7.06 (1H, s, DHDG H-6′), 6.96 [2H, s,
isoDHDG (H-2/H-6)], 6.93 [2H, s, galloyl (H-2/H-6)], 6.89 (1H, s,
isoDHDG H-6′), 6.58 (1H, s, HHDP H-3), 6.51 (1H, s, HHDP H-3′),
1
the H NMR data comparison.
Cytotoxic Activity Assay. HL-60 cells (Riken, Tsukuba, Japan)
were cultured at 37 °C in RPMI1640 supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (Sigma Chemical Corp., St.
Louis, MO, USA), under a humidified 5% CO2 atmosphere. Human
oral squamous cell carcinoma cell lines (HSC-2, HSC-3, HSC-4)
I
dx.doi.org/10.1021/np4001625 | J. Nat. Prod. XXXX, XXX, XXX−XXX